CoChat

Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy

Orme, S. M., Sebastian, J. P., Oldroyd, B., Stewart, S. P., Grant, P. J., Stickland, M. H., Smith, M. A., Belchetz, P. E. · 1992 · Clinical Endocrinology
Cited by 64

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

OBJECTIVE We assessed the effects of the administration of low dose growth hormone in growth hormone deficient adults on body composition and physical performance. We compared the validity of different measures of body composition in GH treated adults. DESIGN An uncontrolled longitudinal study of eight patients with GH deficiency who were treated with 4 units of biosynthetic growth hormone (Norditropin), three times a week. Subjects were studied for 8 weeks. PATIENTS Eight patients with acquired growth hormone deficiency as defined by <5mU/1 GH following standard provocative investigations in whom other hormone replacement was optimized. MEASUREMENTS IGF‐I was measured on day 1 and after 4 and 8 weeks of treatment with recombinant human growth hormone. Body composition was estimated by dual energy X‐ray absorptiometry, bioelectrical impedance, skinfold anthropometry, total body potassium measurement and by computerized tomography of a representative cross‐sectional area of thigh on day 1 and following 8 weeks of treatment. Exercise capacity was measured on an electromechanical bicycle and palmar grip strength was measured using a Jamar dynamometer on day 1 and after 8 weeks. RESULTS IGF‐I increased significantly. Exercise capacity and maximum heart rate achieved on the electromechanical bicycle increased significantly. Grip strength did not change. There was a significant increase in fat‐free mass and a decline in fat mass as shown by dual energy X‐ray absorptiometry and bioelectrical impedance. However, this was not confirmed by other methods. No side‐effects were noted. CONCLUSIONS This study shows that a low dose of biosynthetic growth hormone can elevate IGF‐I levels and have a pronounced physical impact in the growth hormone deficient adult without the side‐effects seen at higher dosage schedules. Over a 2 month period the increase in fat‐free mass may be due to an increase in total body water; however, the decline in fat mass is a genuine effect.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.1992.tb02358.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 64

Metadata

Authors
Orme, S. M., Sebastian, J. P., Oldroyd, B., Stewart, S. P., Grant, P. J., Stickland, M. H., Smith, M. A., & Belchetz, P. E.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
1992-11
Volume
37
Issue
5
Pages
453-459
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2046043073
Cited by
64
References
3
FWCI
3.86
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy. https://app.cochat.ai/papers/10.1111/j.1365-2265.1992.tb02358.x
The paper
Orme, S. M., Sebastian, J. P., Oldroyd, B., Stewart, S. P., Grant, P. J., Stickland, M. H., Smith, M. A., & Belchetz, P. E. (1992). Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.1992.tb02358.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.